Evaluation of ceftriaxone pharmacokinetics in hospitalized Egyptian pediatric patients.

"Declarations Ethics approvalThe ethics committee represented by the Institutional Review Board (IRB) at the Faculty of Medicine, Zagazig University, gave us approval for collecting blood samples from pediatric patients opportunistically during the duration of treatment (Approval Number; ZU-IRB#6070/26/4/2020). The sample was taken as a comprehensive sample due to the rare attendance of cases (4 cases or less/month), so the committee determined the sample to be 24 cases. Consent to participateParents of pediatric patients in this study signed two consent forms previously determined by the IRB committee. The first one (ZU-IRB #: FORM 2) is for initial acceptance to participate in this study. The second one (ZU-IRB #: FORM 3) is for acceptance to obtain blood samples from the patients for this study. Conflict of interestThe authors declare no competing interests. Conflict of interest The authors declare no competing interests."

"Funding Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB)."